Precigen, Inc. financial data

Symbol
PGEN on Nasdaq
Industry
Pharmaceutical Preparations
Location
20374 Seneca Meadows Parkway, Germantown, MD
State of incorporation
VA
Fiscal year end
December 31
Former names
INTREXON CORP (to 1/22/2020)
Latest financial report
10-K - Q4 2024 - Mar 19, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 222 % -26.8%
Debt-to-equity 74.5 % +164%
Return On Assets -116 % -138%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 294M shares +16.5%
Common Stock, Shares, Outstanding 107M shares -57%
Entity Public Float 240M USD +35.3%
Weighted Average Number of Shares Outstanding, Basic 268M shares +9.48%
Weighted Average Number of Shares Outstanding, Diluted 268M shares +9.48%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 22.1M USD -39.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -128M USD -32.9%
Income Tax Expense (Benefit) -1.79M USD -291%
Net Income (Loss) Attributable to Parent -126M USD -31.6%
Earnings Per Share, Basic -0.47 USD/shares -20.5%
Earnings Per Share, Diluted -0.47 USD/shares -20.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 29.5M USD +290%
Cash, Cash Equivalents, and Short-term Investments 97.9M USD +55.7%
Accounts Receivable, after Allowance for Credit Loss, Current 926K USD +2.66%
Assets, Current 102M USD +49%
Property, Plant and Equipment, Net 13.8M USD +94.5%
Operating Lease, Right-of-Use Asset 5.06M USD -28.8%
Intangible Assets, Net (Excluding Goodwill) 4.46M USD -89.1%
Goodwill 19.1M USD -28.1%
Other Assets, Noncurrent 371K USD -51.6%
Assets 145M USD -3.83%
Accounts Payable, Current 3.53M USD +105%
Employee-related Liabilities, Current 8.42M USD +2.02%
Contract with Customer, Liability, Current 589K USD +15.7%
Liabilities, Current 21.5M USD -6.38%
Contract with Customer, Liability, Noncurrent 1.93M USD +6.38%
Deferred Income Tax Liabilities, Net 0 USD -100%
Operating Lease, Liability, Noncurrent 4.55M USD -22.9%
Liabilities 78.5M USD +141%
Accumulated Other Comprehensive Income (Loss), Net of Tax 12K USD
Retained Earnings (Accumulated Deficit) -2.09B USD -6.43%
Stockholders' Equity Attributable to Parent 38.5M USD -67.5%
Liabilities and Equity 145M USD -3.83%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -14.1M USD +23.4%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities 24M USD
Common Stock, Shares Authorized 400M shares 0%
Common Stock, Shares, Issued 293M shares +14.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9.9M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 29.5M USD +276%
Interest Paid, Excluding Capitalized Interest, Operating Activities 3M USD +225%
Deferred Tax Assets, Valuation Allowance 404M USD -4.8%
Deferred Tax Assets, Gross 405M USD -6.5%
Operating Lease, Liability 5.5M USD -22.5%
Depreciation 1.47M USD -19.4%
Payments to Acquire Property, Plant, and Equipment 4.35M USD +2725%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -124M USD -31.7%
Lessee, Operating Lease, Liability, to be Paid 7.38M USD -24%
Property, Plant and Equipment, Gross 36.7M USD +16.9%
Operating Lease, Liability, Current 956K USD -20.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.43M USD -25%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.56M USD -20%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Deferred Income Tax Expense (Benefit) -29K USD +47.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.88M USD -28.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.29M USD -14.7%
Preferred Stock, Shares Issued 79K shares
Preferred Stock, Shares Authorized 25M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.26M USD +1.7%
Operating Lease, Payments 572K USD +23.5%
Additional Paid in Capital 2.13B USD +2.12%
Amortization of Intangible Assets 3.06M USD -36.9%
Depreciation, Depletion and Amortization 1.6M USD -6.78%
Deferred Tax Assets, Net of Valuation Allowance 1.27M USD -86%
Share-based Payment Arrangement, Expense 9.47M USD -4.22%